Atea Pharmaceuticals Inc (AVIR)

$2.96 $0.03 (1.02%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $248.32M

  • Day's Range

    $2.88 - $2.99

  • Volume

    301,048

  • 52 Week Low / High

    $2.86 - $4.60

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

AVIR's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
1
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
$4.00
Target Price

Company News

  • Atea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study — Jan 10th, 2024

    Atea Pharmaceuticals, Inc. AVIR, a clinical-stage company, reported positive initial data from the first 52 patients in the lead-in cohort of the mid-stage study evaluating its bemnifosbuvir and ruzasvir (RZR) combination therapy for the treatment of Hepatitis C Virus (HCV). Bemnifosbuvir...

Similar Stocks

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free